Cargando…
Evaluating the safety of a rotavirus vaccine: the REST of the story
The Rotavirus Efficacy and Safety Trial (REST) was a blinded, placebo-controlled study of the live pentavalent human-bovine vaccine, RotaTeq® (Merck & Co. Inc., West Point, PA). REST was noteworthy because its primary objective was to evaluate the safety of RotaTeq® with regard to intussusceptio...
Autores principales: | Heyse, Joseph F, Kuter, Barbara J, Dallas, Michael J, Heaton, Penny |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Sage
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602609/ https://www.ncbi.nlm.nih.gov/pubmed/18375651 http://dx.doi.org/10.1177/1740774508090507 |
Ejemplares similares
-
Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5)
por: Itzler, Robbin, et al.
Publicado: (2010) -
Challenges and opportunities for conducting a vaccine trial during the COVID-19 pandemic in the United Kingdom
por: Török, M Estée, et al.
Publicado: (2021) -
Using simulated infectious disease outbreaks to inform site selection and sample size for individually randomized vaccine trials during an ongoing epidemic
por: Madewell, Zachary J, et al.
Publicado: (2021) -
EBOVAC-Salone: Lessons learned from implementing an Ebola vaccine
trial in an Ebola-affected country
por: Mooney, Thomas, et al.
Publicado: (2018) -
A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats
por: Longini, Ira M, et al.
Publicado: (2022)